| For: | Mohamet L, Miazga NJ, Ward CM. Familial Alzheimer’s disease modelling using induced pluripotent stem cell technology. World J Stem Cells 2014; 6(2): 239-247 [PMID: 24772250 DOI: 10.4252/wjsc.v6.i2.239] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v6/i2/239.htm |
| Number | Citing Articles |
| 1 |
V C Jones, R Atkinson-Dell, A Verkhratsky, L Mohamet. Aberrant iPSC-derived human astrocytes in Alzheimer's disease. Cell Death & Disease 2017; 8(3) doi: 10.1038/cddis.2017.89
|
| 2 |
Anna Slanzi, Giulia Iannoto, Barbara Rossi, Elena Zenaro, Gabriela Constantin. In vitro Models of Neurodegenerative Diseases. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00328
|
| 3 |
Ghanshyam Upadhyay, Sharmila Shankar, Rakesh K. Srivastava. Stem Cells in Neurological Disorders: Emerging Therapy with Stunning Hopes. Molecular Neurobiology 2015; 52(1) doi: 10.1007/s12035-014-8883-6
|
| 4 |
Lisa Mohamet, Vicky C Jones, Govindan Dayanithi, Alexei Verkhratsky. Pathological Human Astroglia in Alzheimer's Disease: Opening New Horizons with Stem Cell Technology. Future Neurology 2018; 13(2) doi: 10.2217/fnl-2017-0029
|
| 5 |
Shyanne Page, Ronak Patel, Snehal Raut, Abraham Al-Ahmad. Neurological diseases at the blood-brain barrier: Stemming new scientific paradigms using patient-derived induced pluripotent cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(4) doi: 10.1016/j.bbadis.2018.12.009
|
| 6 |
Subashchandrabose Chinnathambi. Immunomodulators - Part A. Advances in Protein Chemistry and Structural Biology 2026; 151 doi: 10.1016/bs.apcsb.2025.10.005
|
| 7 |
Mercedes A. Hernández-Sapiéns, Edwin E. Reza-Zaldívar, Ricardo R. Cevallos, Ana L. Márquez-Aguirre, Karlen Gazarian, Alejandro A. Canales-Aguirre. A Three-Dimensional Alzheimer’s Disease Cell Culture Model Using iPSC-Derived Neurons Carrying A246E Mutation in PSEN1. Frontiers in Cellular Neuroscience 2020; 14 doi: 10.3389/fncel.2020.00151
|
| 8 |
Panetha Pansri, Phetcharat Phanthong, Nopparat Suthprasertporn, Yindee Kitiyanant, Alisa Tubsuwan, Andras Dinnyes, Julianna Kobolak, Narisorn Kitiyanant. Brain-derived neurotrophic factor increases cell number of neural progenitor cells derived from human induced pluripotent stem cells. PeerJ 2021; 9 doi: 10.7717/peerj.11388
|
| 9 |
Se Hoon Choi, Young Hye Kim, Luisa Quinti, Rudolph E. Tanzi, Doo Yeon Kim. 3D culture models of Alzheimer’s disease: a road map to a “cure-in-a-dish”. Molecular Neurodegeneration 2016; 11(1) doi: 10.1186/s13024-016-0139-7
|
| 10 |
Pernille S. Lassen, Camilla Thygesen, Martin R. Larsen, Stefan J. Kempf. Understanding Alzheimer's disease by global quantification of protein phosphorylation and sialylated N-linked glycosylation profiles: A chance for new biomarkers in neuroproteomics?. Journal of Proteomics 2017; 161 doi: 10.1016/j.jprot.2017.04.003
|
| 11 |
Se Hoon Choi, Carla D’Avanzo, Young Hye Kim, Enjana Bylykbashi, Matthias Hebisch, Oliver Brüstle, Ruldolph E. Tanzi, Doo Yeon Kim. Stem Cell Technologies in Neuroscience. Neuromethods 2017; 126 doi: 10.1007/978-1-4939-7024-7_1
|
| 12 |
Christos Tsagkaris, Dimitrios V. Moysidis, Andreas S. Papazoglou, Andleeb Khan, Stavros Papadakos, Anna Maria Louka, Dorothy Martha Scordilis, Anastasiia Shkodina, Kyriakoula Varmpompiti, Gaber El-Saber Batiha, Athanasios Alexiou. Proteins Associated with Neurodevelopmental Disorders. Nutritional Neurosciences 2022; doi: 10.1007/978-981-15-9781-7_14
|
| 13 |
Xianmin Zeng, Joshua G. Hunsberger, Anton Simeonov, Nasir Malik, Ying Pei, Mahendra Rao. Concise Review: Modeling Central Nervous System Diseases Using Induced Pluripotent Stem Cells. Stem Cells Translational Medicine 2014; 3(12) doi: 10.5966/sctm.2014-0102
|
| 14 |
Cong He, Baojiang Chen, Ciai Yan, Xiaoqing Zhou. Stem cell and CRISPR/Cas9 gene editing technology in Alzheimer’s disease therapy: from basic research to clinical innovation. Frontiers in Genome Editing 2025; 7 doi: 10.3389/fgeed.2025.1612868
|
| 15 |
Snehal Raut, Ronak Patel, Abraham J. Al-Ahmad. Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro. Fluids and Barriers of the CNS 2021; 18(1) doi: 10.1186/s12987-020-00235-y
|
| 16 |
Ling Li, Hee Jin Kim, Jee Hoon Roh, Minchul Kim, Wonyoung Koh, Younghoon Kim, Hyohoon Heo, Jaehoon Chung, Mahito Nakanishi, Taeyoung Yoon, Chang Pyo Hong, Sang Won Seo, Duk L. Na, Jihwan Song. Pathological manifestation of the induced pluripotent stem cell‐derived cortical neurons from an early‐onset Alzheimer's disease patient carrying a presenilin‐1 mutation (S170F). Cell Proliferation 2020; 53(4) doi: 10.1111/cpr.12798
|
| 17 |
Carla D'Avanzo, Jenna Aronson, Young Hye Kim, Se Hoon Choi, Rudolph E. Tanzi, Doo Yeon Kim. Alzheimer's in 3D culture: Challenges and perspectives. BioEssays 2015; 37(10) doi: 10.1002/bies.201500063
|
| 18 |
Jeremy Micah Crook, Gordon Wallace, Eva Tomaskovic-Crook. The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy. Expert Review of Neurotherapeutics 2015; 15(3) doi: 10.1586/14737175.2015.1013096
|
| 19 |
Ling Li, Jee Hoon Roh, Hee Jin Kim, Hyun Jung Park, Minchul Kim, Wonyoung Koh, Hyohoon Heo, Jong Wook Chang, Mahito Nakanishi, Taeyoung Yoon, Duk L. Na, Jihwan Song. The First Generation of iPSC Line from a Korean Alzheimer's Disease Patient Carrying APP-V715M Mutation Exhibits a Distinct Mitochondrial Dysfunction. Experimental Neurobiology 2019; 28(3) doi: 10.5607/en.2019.28.3.329
|
| 20 |
Riya R. Kanherkar, Naina Bhatia-Dey, Evgeny Makarev, Antonei B. Csoka. Cellular reprogramming for understanding and treating human disease. Frontiers in Cell and Developmental Biology 2014; 2 doi: 10.3389/fcell.2014.00067
|
| 21 |
Renzo J. M. Riemens, Edilene S. Soares, Manel Esteller, Raul Delgado-Morales. Neuroepigenomics in Aging and Disease. Advances in Experimental Medicine and Biology 2017; 978 doi: 10.1007/978-3-319-53889-1_23
|